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INTRODUCTION
Familial amyloid polyneuropathy
(FAP) is an autosomal dominant heredi-
tary disease characterized by the extra-
cellular deposition of amyloid fibrils in
the connective tissue, affecting the pe-
ripheral nervous system in particular
(1,2). The onset of clinical symptoms
generally occurs before age 40, with a
progressive and severe sensory and auto-
nomic neuropathy leading to death in
about 10–20 years.
FAP amyloidoses are related to single
transthyretin (TTR) amino acid substitu-
tions in which the mutated protein leads
to extracellular amyloid fibril deposition.
Although more than 80 transthyretin
mutations associated with TTR amyloi-
dosis have been described (3), the most
common variant has a valine substituted
by a methionine at position 30 (V30M)
(4). TTR is a 55-kDa homotetrameric pro-
tein synthesized mainly in the liver, eye,
and choroid plexus, and its main func-
tion is the transport of thyroxin (T4) and
vitamin A (retinol) associated with the
retinol binding protein.
Why mutated TTR deposits in the
form of amyloid is unknown, but x-ray
crystallographic studies of TTR mutants
related to aggressive forms of FAP show
conformational changes in this protein
(5). These changes may lead to tetramer
dissociation into a nonnative TTR
monomer with low conformational sta-
bility, which results in partially unfolded
monomeric species with a strong ten-
dency to aggregate (6). Pathogenic events
associated with TTR deposition in FAP
patients have been investigated by analy-
ses of nerve and salivary gland tissues
from FAP patients and asymptomatic
V30M carriers; cytotoxicity begins in a
presymptomatic stage of the disease,
with nonfibrillar TTR aggregates trigger-
ing oxidative damage, inflammatory re-
sponses, induction of the nuclear tran-
scription factor kB (NFkB) pathway, and
activation of caspase-3 before amyloid
fibrillar deposition (7,8). Increased levels
of the endoplasmic reticulum (ER) stress
sensor BiP were found to correlate with
the extracellular TTR deposition ob-
served in salivary gland tissue from FAP
patients (9).
Early detection of pathological lesions
through the use of biomarkers may aid
in correct clinical management of pa-
tients and possible delay of morbidity.
In this regard, animal models of TTR
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deposition with defined sets of correla-
tive biomarkers are essential tools to
test and guide the application of pro-
phylactic and therapeutic drugs before
clinical testing.
Mice transgenic for human TTR V30M
in a null background (hTTR Met30) serve
as animal models for TTR deposition.
Nonfibrillar deposition begins when the
mice are three months old, and the de-
posits evolve to amyloid fibrils when the
mice are nine months old, with particu-
lar involvement of the gastrointestinal
tract and skin (10). hTTR Met 30 mice
have already been used to demonstrate
that TTR deposits can be removed by an
immunization protocol with a TTR vari-
ant expressing a cryptic epitope, TTR
Y78F (11).
By crossing hTTR Met 30 mice to mice
with a heat shock transcription factor 1
(HSF1) null background, a novel trans-
genic mouse model was generated, hTTR
Met30/HSF1-KO. This new mouse
model shows TTR deposition in the pe-
ripheral [dorsal root ganglia (DRG) and
nerve] and autonomic nervous systems,
a deposition pattern not observed in
hTTR Met30 models (12).
We sought to define new, reliable ox-
idative stress and apoptotic biomarkers
associated with TTR deposition in
human clinical samples and in transgenic
mouse models before and after deposi-
tion removal by immunization.
MATERIALS AND METHODS
Human Samples
Labial minor salivary gland biopsy
specimens were obtained from V30M
FAP patients before they underwent liver
transplantation (13), the only available
treatment for this disorder. Control sali-
vary gland tissue samples were from
non-FAP volunteer individuals who had
no evidence of infection. The collection
of biopsy material was approved by the
ethics committee of Hospital Geral de
Santo António, Porto, Portugal, and all
specimen donors gave informed consent.
For immunohistochemical (IHC) anal-
ysis, salivary gland samples were col-
lected into 4% paraformaldehyde in PBS.
The general characterization of salivary
gland tissue consisted of TTR immuno-
histochemistry and analysis of the pres-
ence of amyloid deposits by Congo red
(CR) staining. Salivary gland tissues with
TTR deposition and with amyloid de-
posits were classified as FAP.
Transgenic Mice
Transgenic mice bearing the human
TTR V30M in a TTR null background
(hTTR Met300) and transgenic mice ex-
pressing the human TTR V30M crossed
into an HSF1 null background (hTTR
Met30/HSF1-KO) were used for the ex-
periments (10,12). In this case, we ana-
lyzed animals heterozygous for HSF1,
labeled as hTTR Met30/(+/–) HSF1-KO.
Animals were killed after administra-
tion of ketamine/xylazine anesthesia.
DRG and stomachs were dissected and
fixed in 4% paraformaldehyde, embed-
ded in paraffin, and cut into 5-μm sec-
tions. The animals were housed in path-
ogen-free conditions in a controlled
temperature room maintained with 12-
hour light/dark periods. Water and
food were freely available. All animal
experiments were carried out in accor-
dance with the European Communities
Council Directive.
Immunohistochemistry
Sections (5-μm thick) were deparaffi-
nated in histoclear (National Diagnostics,
Atlanta, GA, USA) and dehydrated in a
descent alcohol series. Endogenous per-
oxidase activity was inhibited with 3%
hydrogen peroxide/100% methanol, and
sections were blocked in 4% fetal bovine
serum and 1% bovine serum albumin in
PBS. Primary antibodies used were: rab-
bit polyclonal anti–thioredoxin 1 (Trx1)
(1:500; Chemicon, Temecula, CA, USA),
rabbit polyclonal anti–glutaredoxin 1
(Grx1) (1:500; Abcam, Cambridge, UK),
goat polyclonal anti–8-hydroxy-2′-
deoxyguanosine (8-OHdG) (1:1000 with
proteinase K epitope retrieval; Chemicon),
goat polyclonal anti–4-hydroxynonenal
(HNE) (1:500; Abcam), mouse mono-
clonal for active caspase-8 (1:200; Cell
Signaling, Danvers, MA, USA), rabbit
polyclonal for active caspase-3 (1:50; Cell
Signaling), rabbit polyclonal for active
caspase-9 (1:20; Abcam), rabbit poly-
clonal anti-Fas (antihuman CD95) (1:100;
Santa Cruz Biotechnology, Santa Cruz,
CA, USA), rabbit polyclonal anti–Fas L
(antihuman CD95 ligand) (1:50; Santa
Cruz Biotechnology), rabbit polyclonal
anti-Bax (1:50; Santa Cruz), rabbit poly-
clonal anti-Bcl2 (1:100; Santa Cruz
Biotechnology), and rabbit polyclonal
anti–Apaf-1 (apoptotic protease-
activating factor 1) (1:100 with citrate
buffer epitope retrieval; Abcam), which
were diluted in blocking solution and in-
cubated overnight at 4ºC. Antigen visual-
ization was performed with the biotin-
extravidin-peroxidase kit (Sigma, St.
Louis, MO, USA), using 3-amino-9-ethyl
carbazole (Sigma) as substrate. On paral-
lel control sections, the primary antibody
was replaced by blocking buffer and by
nonimmune immunoglobulins corre-
sponding to the species used as primary
antibodies, namely rabbit and goat;
staining was absent in all the cases.
Semiquantitative analysis of IHC im-
ages was done with the Universal Imag-
ing system (NIH), which performs auto-
mated particle analysis in a measured
area, i.e., the area occupied by pixels cor-
responding to the IHC substrate color is
counted and normalized relative to the
total area. Each slide was analyzed in
five different selected areas. Results
shown represent the percentage occupied
area ± SD.
Initially, tissues of transgenic mice
were selected for TTR deposition by IHC
analysis using a rabbit polyclonal anti-
TTR (1:1000; Dako, Carpinteria, CA,
USA). TTR-positive–CR-negative tissues
were classified as (+/–) and TTR-
positive–CR-negative tissues as (–/–).
Expression of several markers was com-
pared in hTTR Met30 mice with TTR
deposition in the stomach and age-
matched mice (six months old) without
TTR deposition in the stomach. The same
type of evaluation was performed for
stomach and DRG deposition in hTTR
Met30/HSF1-KO mice.
5 8 6 |  M A C E D O  E T  A L .  |  M O L  M E D  1 3 ( 1 1 - 1 2 ) 5 8 4 - 5 9 1 ,  N O V E M B E R - D E C E M B E R  2 0 0 7
B I O M A R K E R  S E A R C H  I N  F A P
Statistical Analysis
Group values, expressed as the mean ±
SD, were compared by Student t test, and
P values <0.05 were considered significant.
RESULTS
Tissue Markers for Oxidative Stress
Several markers of oxidative damage
have been widely studied in different
pathologies, such as Alzheimer disease
(14), and include 8-OHdG, HNE, glutare-
doxins such as Grx1, and thioredoxins
such as Trx1. We investigated the expres-
sion of HNE, 8-OHdG, Grx1, and Trx1 in
biopsy specimens from human salivary
glands and in tissues from two FAP ani-
mal model strains.
IHC analyses for the lipid peroxidation
biomarker HNE were performed in sali-
vary gland tissue biopsies from V30M
FAP individuals (n = 5) and non-FAP
controls (n = 4). In FAP-patient salivary
gland tissue, HNE was increased by ap-
proximately 50% compared with controls
(Figure 1A); the immunostaining was ex-
clusively cytoplasmic and was present in
epithelial cells in salivary gland excre-
tory ducts, at the same location of TTR
fibrillar amyloid deposits (13). This result
is in accordance with a previous report
of the involvement of lipid peroxidation
in colon biopsies of FAP patients (15). In
addition, we investigated a possible cor-
relation between nonfibrillar TTR depo-
sition and HNE levels in the transgenic
mice strains under study. In the stomach
and DRG in both hTTR Met30 and hTTR
Met30/(+/–)HSF1-KO transgenic mice,
HNE were significantly increased in mice
with TTR deposition compared to mice
without TTR deposition (Figure 1A).
Quantification of IHC images of HNE
staining revealed that HNE was in-
creased approximately 70% in the stom-
ach and 80% in the DRG (Figure 1A),
correlating with nonfibrillar TTR deposi-
tion. These results validate the use of
hTTR Met30 and hTTR Met30/
(+/–)HSF1-KO mice models as tools for
lipid peroxidation studies in FAP.
Although 8-OHdG DNA oxidation has
been extensively investigated in other
neurodegenerative pathologies, this
Figure 1. (A) Top panels: Representative 4-hydroxy-2-nonenal (HNE) staining of salivary glands from healthy individuals (left, n = 6) and
FAP patients (right, n = 6). Middle panels: Representative HNE staining in stomach tissue of hTTR Met30 mice without TTR deposition (–/–,
left, n = 5) and with TTR deposition (+/–, right, n = 5) and in stomach tissue of hTTR Met30/(+/–)HSF1-KO mice, without TTR deposition (–/–,
left, n = 5) and with TTR deposition (+/–, right, n = 5); Lower panel: Representative HNE staining in DRG of hTTR Met30/(+/–)HSF1-KO mice
without TTR deposition (–/–, left, n = 4) and with TTR deposition (+/–, right; n = 4). 20× magnification. Quantitation of IHC images of HNE
staining are represented as percentage of occupied area ± SD (*P < 0.05; **P < 0.01, and # P < 0.005). (B) Top panels: Representative
8-OHdG staining of salivary glands from healthy individuals (left, n = 6) and FAP patients (right, n = 6). Middle panels: Representative
8-OHdG staining in stomach tissue of hTTR Met30 mice without TTR deposition (–/–, left, n = 5) and with TTR deposition (+/–, right, n = 5)
and in stomach tissue of hTTR Met30/(+/–)HSF1-KO, without TTR deposition (–/–, left, n = 6) and with TTR deposition (+/–, right, n = 6); Lower
panel: Representative 8-OHdG staining in DRG tissue of hTTR Met30/(+/–)HSF1-KO mice without TTR deposition (–/–, left, n = 4) and with
TTR deposition (+/–, right; n = 5). 20_ magnification. Quantitation of IHC images of 8-OHdG staining are represented as percentage of
occupied area ± SD (*P < 0.05 and #P < 0.005).
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study is the first to assess 8-OHdG DNA
oxidation in FAP patients. Immunostain-
ing of FAP salivary gland tissue samples
revealed 50% more oxidized DNA than
in control samples (Figure 1B). The in-
crease in DNA oxidation was even more
dramatic in the transgenic mice strains
under study. Stomach tissue from trans-
genic hTTR Met30 mice with TTR aggre-
gates showed approximately 75% more
8-OHdG than tissues without TTR depo-
sition (Figure 1B), and in hTTR Met30/
(+/–)HSF1-KO mice we confirmed ap-
proximately the same level of increase in
DRG (Figure 1B). Thus, we validated the
use of these animal models as tools to in-
vestigate oxidative stress involving DNA
damage.
Finally, IHC studies on salivary glands
revealed that Grx1 is up-regulated in
FAP individuals with TTR deposition
compared with normal individuals (Fig-
ure 2); in contrast, Trx1 levels did not dif-
fer in FAP and control individuals (Fig-
ure 2). Grx1 resides mainly in the
cytosol, although it may translocate into
the nucleus in response to certain stim-
uli. For example, in the brains of patients
with Alzheimer disease, control samples
revealed Grx1 was located mainly in the
cytosolic compartment, contrary to the
nuclear staining in Alzheimer disease
neurons (16). In our study nuclear
translocation of Grx1 was evident in FAP
salivary glands (indicated by arrows in
Figure 2).
We then investigated Trx1 and Grx1
endogenous antioxidant systems in hTTR
transgenic mice. In both hTTR Met30 and
hTTR Met30/(+/–)HSF1-KO mice, in-
creased Grx1 was associated with TTR
deposition in the stomach (Figure 2) but
Trx1 was not (not shown). In the periph-
eral nervous system of hTTR Met30/
(+/–)HSF1-KO mice, represented by
DRG tissue samples, Grx1 and Trx1 were
both up-regulated in samples with TTR
deposition (Figure 2).
Tissue Markers for Apoptosis
We investigated the Fas death receptor
in FAP salivary glands and in FAP trans-
genic mouse models and observed that
although there were no differences in
FasL expression (Figure 3), FAP salivary
glands expressed higher amounts of the
receptor protein, probably related to in-
creased activation of this apoptosis-
initiating cascade (Figure 3). We next
evaluated the cleavage of caspase sub-
strates in FAP salivary glands. In FAP
salivary glands, both the initiator cas-
pase-8 as well as the effector caspase-3
were cleaved more extensively compared
with controls (Figure 3), presenting as
much as 70% increase in activation.
However, no differences were found for
caspase-9 activation (not shown).
We then investigated the role of Bcl-2
family proteins in FAP biopsies. We did
not find differences in Bcl-2 or Apaf-1
levels between FAP and control salivary
gland tissue (not shown), concordant
Figure 2. Top 2 panels: Representative Grx1 and Trx1 staining of salivary glands from
healthy individuals (left, n = 6) and FAP patients (right, n = 6); nuclear staining is indicated
by the arrow. Middle panel: Representative Grx1 staining in stomach tissue of hTTR Met30/
(+/–)hsf mice without TTR deposition (–/–, left, n = 5) and with TTR deposition (+/–, right, n =
5). Lower 2 panels: Representative Grx1 and Trx1 staining in DRG tissue of hTTR Met30/
(+/–)HSF1-KO mice without TTR deposition (–/–, left, n = 4) and with TTR deposition (+/–,
right; n = 5); nuclear staining is indicated by the arrow. 20× and 40× magnification (inset).
Quantitation of IHC images of Grx1 and Trx1 staining are represented as percentage of
occupied area ± SD (*P < 0.05).
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with the results on caspase-9, which did
not show evidence for activation. Because
Bax and Bak are proapoptotic proteins
that initiate mitochondrial dysfunction
but also localize to the ER (17) we next
assessed Bax levels in salivary gland tis-
sue samples. A slight, but not significant,
increase was detected in FAP glands com-
pared with controls (Figure 3).
We further investigated a possible cor-
relation between nonfibrillar TTR depo-
sition and the above-defined markers of
apoptosis in the mice transgenic for
human TTR V30M and the novel hTTR
Met30/(+/–)HSF1-KO mice. A dramatic
increase in the Fas death receptor signal
was observed in tissues with TTR depo-
sition in the transgenic mouse strains
under study. Transgenic hTTR Met30
mice presented an increase of approxi-
mately 75% in Fas in the stomach of
TTR-positive animals (Figure 4), and the
same differences were observed in the
stomach and DRG of hTTR Met30/
(+/–)HSF1-KO mice (Figure 4) in TTR-
positive compared with deposit-free tis-
sues. As in human salivary gland tissue,
FasL was expressed at the same levels in
mouse tissues with or without TTR dep-
osition (data not shown).
We found increased levels of Bax (Fig-
ure 4) associated with TTR deposition in
the stomach of both transgenic mice
strains as well as in DRG from hTTR
Met30/(+/–)HSF1-KO mice (Figure 4).
Based on these results, we believe that
the apoptotic pathway mediated by the
Fas receptor is definitely involved in
neurotoxicity observed in FAP salivary
gland tissue and in the animal models
under study that present TTR deposition,
and in FAP in general.
Oxidative Stress and Apoptotic
Markers after TTR Removal
IHC analyses of tissues from trans-
genic hTTR Met30 mice immunized with
Y78F and presenting with TTR removal
revealed a decrease in some of the mark-
ers described above. We tested one
marker of oxidative stress, 8-OHdG, a
radical-damaged guanine nucleotide rep-
resentative of oxidation at the DNA
level; two markers of apoptosis, the
death receptor Fas and the pro-apoptotic
Bax; the ER chaperone BiP; and the en-
dogenous antioxidant protein Grx1.
IHC analysis of the gastrointestinal
tract of TTR Y78F immunized mice (n =
6) revealed decreased levels of these
markers in the stomach compared with
nonimmunized age-matched controls
(n = 6). The decrease was approximately
50% for Fas and BiP and was even more
dramatic, approximately 70%, for the ox-
idative stress markers 8-OHdG and
Grx1. Although Bax levels were lower in
the tissues of immunized mice, the dif-
ference was not significant (Figure 5).
These results correlate with the de-
crease of TTR in the stomach of TTR
Y78F immunized animals reported by
Terazaki et al. (11), further validating the
use of 8-OHdG, Grx1, Fas, and BiP for
follow-up of therapeutic approaches in
FAP patients.
DISCUSSION
We generated a set of biomarkers as-
sociated with FAP pathology by the use
of salivary gland tissue from FAP pa-
Figure 3. Representative FasL, Fas, active caspase-8, active caspase-3, and Bax staining of
salivary glands from healthy individuals (left, n = 6) and FAP patients (right, n = 6). 20× mag-
nification. Quantitation of IHC images of FasL, Fas, active caspase-8, active caspase-3, and
Bax staining are represented as percentage of occupied area ± SD (*P < 0.05).
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tients with amyloid deposition and
unique tissues, stomach and DRG from 2
different animal models with nonfibril-
lar TTR deposition, that resemble the
asymptomatic phase of the disease. A
major novel finding from our study was
the detection of specific oxidative and
apoptotic markers not only in amyloid-
laden tissues, but also before amyloid
deposition, in tissues presenting nonfib-
rillar deposition. The biomarkers we
found to be associated with deposition
did not deviate considerably from those
found in other neurodegenerative disor-
ders; for instance, in Alzheimer disease
abnormal oxidative metabolites, includ-
ing HNE and cholesterol-derived alde-
hydes, have been reported to modify 
Aβ and accelerate the early stages of
amyloidogenesis (18). The biomarker
8-OHdG, a modified base that occurs in
DNA due to attack by hydroxyl radicals
formed as byproducts and intermediates
of aerobic metabolism and during oxida-
tive stress, has been increasingly used as
a sensitive, stable, and integral marker
of oxidative damage in cellular DNA
(19). In a neuroblastoma cell line, Aβ fib-
rils caused transient oxidation of both
Grx1 and Trx1 (16). Cytosolic mam-
malian Trx1 has numerous functions in
defense against oxidative stress, control
of growth, and apoptosis. Grx1 catalyses
glutathione disulfide oxireductions,
overlapping the functions of thioredox-
ins and using electrons from NADPH
via glutathione reductases (20). Despite
the importance of Grx1 and Trx1 as reg-
ulators of oxidative stress and apoptosis,
their role in FAP is completely un-
known. We believe that overexpression
of Grx1 may have a protective role, act-
ing to detoxify FAP tissues as it does the
frontal cortex and hippocampal neurons
of the brain in Alzheimer disease (16).
Trx1 was not up-regulated in the ana-
lyzed tissues with TTR deposition, ex-
cept for DRG, probably because salivary
glands and stomach mucosa are in con-
tact with multiple stimuli and irritations.
The Trx1 system is probably activated in
a constant way by contact with external
stimuli, whereas Grx1 better protects
against cellular injury. In addition to
measurement of the levels of these pro-
teins, their reduced and oxidized states
should also be investigated, because un-
derstanding of the downstream cascades
that Grx1 and Trx1 trigger will elucidate
the roles of Trx1 and Grx1 in TTR amy-
loidosis and may lead to the develop-
ment of therapeutic interventions to
modulate these markers.
Figure 4. Representative Fas (upper panels) and Bax (bottom panels) staining in stomach
and DRG tissue of TTR transgenic mice. Upper panels: Stomach tissue of hTTR Met30 mice
without TTR deposition (–/–, left, n = 5) and with TTR deposition (+/–, right, n = 5), of hTTR
Met30/(+/–)HSF1-KO, without TTR deposition (–/–, left, n = 6) and with TTR deposition (+/–,
right, n = 6) and DRG tissue of hTTR Met30/(+/–)HSF1-KO mice without TTR deposition (–/–,
left, n = 6) and with TTR deposition (+/–, right; n = 6). Bottom panels: the same organiza-
tion as above. 20× magnification. Quantitation of IHC images of Fas and Bax staining are
represented as percentage of occupied area ± SD (*P < 0.05).
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Apoptotic features are present exten-
sively in the most common neurodegen-
erative diseases. Previous studies have
evaluated Aβ-induced apoptotic cell
death in cerebral endothelial cells by in-
vestigation of increased oxidative stress,
caspase activation, mitochondrial dys-
function, and DNA damage (21).
The evidence we obtained for Fas and
caspase-8 activation in tissues with TTR
deposition suggest activation of death-
receptor pathways not involving the mi-
tochondria (22,23); a possible explana-
tion for caspase-8 activation is the
induction of Fas-associated death
domain–independent pathways deriving
from prolonged activation of extracellu-
lar signal-regulated kinases 1 and 2
(ERK1/2) (24) and activation of ERK1/2,
which was shown in FAP salivary gland
tissue and nerves and in tissues from
TTR transgenic mice presenting TTR
deposition (25). Further suggestion for a
secondary role of mitochondrial involve-
ment was the lack of evidence in the
present study for changes in Bcl2 and
Apaf-1 in tissues with TTR deposition
(22,26). Additional studies regarding
morphological and functional alterations
in mitochondria, namely the measure-
ment of mitochondrial membrane poten-
tial, should clarify this issue as tested in
another model system (27). Moreover,
the trophic signals relayed from TTR to
mitochondria remain elusive, with a
possible role of intracellular Ca2+ re-
maining to be investigated. The ER
contributes to pathways in FAP, a char-
acteristic that differs from other neu-
rodegenerative protein misfolding disor-
ders and is suggestive of different
pathways involved in apoptosis, possi-
bly related to the fact that in FAP protein
aggregation occurs extracellularly rather
than intracellularly. Recent data showed
activation of the classical unfolded-pro-
tein response pathways in tissues not
specialized in TTR synthesis but present-
ing extracellular TTR aggregate and fib-
ril deposition. We have previously
demonstrated cytotoxicity by Ca2+ efflux
from the ER in cell cultures incubated
with TTR oligomers, evidence for ER
stress associated with extracellular
aggregates (9).
We have demonstrated that the bio-
markers of oxidative stress and apopto-
sis we investigated are correlated with
TTR deposition, as corroborated by the
results in tissues from which deposition
was removed by immunization. These
results confirm the usefulness of this set
of biomarkers in the follow-up of thera-
peutic approaches and highlight the im-
portance of pursuing FAP treatments
based on antioxidative and antiapoptotic
therapies.
Figure 5. Representative immunohistochemistry of TTR, BiP, Fas, Bax, 8-OHdG and Grx1 in
stomach tissue of TTR Y78F immunized transgenic mice 9-10 months old (right; n = 6) and
nonimmunized age-matched controls (left; n = 6). 20× magnification; Quantification of
IHC images of TTR, BiP, Fas, Bax, 8-OHdG, and Grx1 staining are represented as percent-
age of occupied area ± SD (*P < 0.05, #P < 0.005).
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